Relation of Neutrophil/Lymphocyte Ratio to GRACE Risk Score to In-hospital Cardiac Events in Patients with ST-Elevated Myocardial Infarction  by Öncel, Ramazan Can et al.
Table 1. Comparison Of Distinctive Features of PatientsWith andWithout fQRS
(HT: hypertension, DM: diabetes mellitus, HL: hyperlipidemia, SBP: systolic blood pressure,
DBP: diastolic blood pressure, LVEF: left ventricular ejection fraction, HBG: hemoglobin, WBC:
white blood cell count, MPV: mean platelet volume, PLT: platelet count, BUN: blood urea
nitrogen, LDL: low density lipoprotein, HDL: high density lipoprotein, CK-MB: creatinine kinase-
muscle band, MI: myocardial infarction)
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There are many randomized controlled trials comparing outcomes for Percutaneous
coronary intervention (PCI) and optimal medical therapy alone (OMT) for stable coronary
artery disease patients whereas little is known about medication adherence PCI versus
OMT in a setting apart from randomized controlled trials. Although medication adherence
in randomized controlled trials like COURAGE is quite high, in real life these rates are
lower. In this study of 232 documented CAD (coronary artery disease) patients, we
compared statin, beta blocker and ACE-inhibitors adherence during six-month follow-up
between patients treated with PCI and those receiving medical therapy alone. Medication
adherence was measured by National reimbursement database records Of the 232 patients
who survived to the 6-month followup, the prespeciﬁed primary end point of percentage of
patients adherent by prescription records were 33.8% (n¼27) in OMT group and 53.6%
(n¼82) in PCI group, p¼0.004 (Figure 1). Analysis for the individual medication classes
revealed similar results for beta blockers (86.0% in PCI group vs 72.5% in OMT group,
p¼0.006) and statins (64.5% in PCI group vs 44.0% in OMT group, p¼0.003).
Adherence to ACE inhibitors was also higher in PCI group without statistical
signiﬁcance (77.6% vs 69.3%, p¼0.17). In the present study we demonstrated that
medication adherence to evidence based therapies in stable coronary artery disease
patients in PCI group is signiﬁcantly higher than OMT group.C22 JACC VOP-057
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Objectives: Neutrophil/Lymphocyte ratio (NLR) is being increasingly used as
a marker for cardiovascular risk assessment and as a prognostic tool in ST-elevated
myocardial infarction (STEMI). In this study, we aimed to investigate the association
of the NLR with GRACE risk score and in-hospital major advanced cardiac events in
patients with STEMI undergoing primary percutaneous coronary intervention (PCI).
Material/Methods: We analyzed 101 consecutive STEMI patents treated with
primary PCI. Patients were divided into 3 groups by use of GRACE risk score. The
NLR was calculated as a part of automated complete blood count. The association
between NLR and GRACE risk score was assessed.
Results: Baseline Characteristics.
The study population consisted of 101 consecutive STEMI patients. 80.2%of patients
were male and mean age of patients was 57.9712.24 years. 42 patients were hyper-
tensive,23 patients were diabetic,34 patients were hyperlipidemic and 57 were smoker.
According to the GRACE risk score,21 patients had low GRACE risk scores,48
patients had intermediate GRACE risk scores, 32 patients had high GRACE risk
scores. Demographic and biochemical characteristics of patients in GRACE risk score
groups are shown in table 1. The NLR showed a proportional increase correlated with
GRACE risk score (p<0.001) (Table 1, Figure 1).
Correlation With In-Hospital Events
During the in-hospital period, 11 patients (10.9%) presented cardiac events (3 cardiac
death, 2 reinfarction, 6 new-onset heart failure). These patients hadmore advancedKillip
functional class and higher GRACE risk score. The occurrence of in hospital cardiac
death, reinfarction or new-onset heart failure was signiﬁcantly related to NLR at
admission (8.181.16 vs. 3.071.77, p<0.001). Likewise,NLR andGRACE risk score
showed a signiﬁcant positive correlation (r¼0.803, p<0.001) (Figure 2).
Multivariate Analysis
For in hospital cardiac events; N/L ratio,blood glucose level upon admission,
troponin level at admission and in hospital GRACE death point were analyzed using
a multivariate logistic regression model. The NLR was the only independent predictor
of in-hospital cardiac events (odds ratio 3.63, conﬁdence interval 95%: 1.31-10.04,
p¼0.013) (Table 2).
Discussion: NLR has recently emerged as a potential new biomarker which singles
out individuals at risk for future cardiovascular events in STEMI patients. Unlike
many other inﬂammatory markers and bioassays, NLR is an inexpensive and readily
available marker that provides an additional level of risk scores in predicting inhos-
pital and long-term outcomes. Although the GRACE risk score is routinely used for
stratiﬁcation of patients with acute coronary syndrome, NLR may provide additional
prognostic value. Increased NLR is independently associated with a higher rate of in-
hospital cardiac events. The determination of NLR for risk stratiﬁcation of STEMI
patients during hospitalization may be useful.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
Table 1
Variables
GRACE
<108 points
GRACE
108-140 points
GRACE
>140 points p
Age, years 48.338.77z 55.528.87z,yy 67.9711.7*,y <0.001
Men, n (%) 16 (76.2%) 43 (89.6%) 22 (68.8%) 0.063
BMI, kg/m2 28.063.70 27.274.09 26.403.20 0.449
HT, n (%) 9 (42.9%) 13 (21.7%) 20 (62.5%) 0.007
DM, n (%) 3 (14.3%) 11 (22.9%) 9 (28.1%) 0.501
HPL, n (%) 11 (52.4%) 13 (27.1%) 10 (31.3%) 0.116
Smoker,
n (%)
15 (71.4%) 28 (58.3%) 14 (43.8%) 0.130
Glucose,
(mg/dl)
162.864.0 151.452.1 192.2131.4 0.745
WBC, cells/ml 124593041 122693643 117874113 0.492
Neutrophil, % 54.6412.15y,z 65.595.82*,z 79.25.25*,y <0.001
Lymphocyte, % 37.426.42y,z 25.704.47*,z 13.444.32*,y <0.001
NLR 1.520.50y,z 2.650.65*,z 6.481.99*,y <0.001
TroponinT,
ng/dl
0.180.64z 0.631.86z,** 1.061.57*,y <0.001
Demographic and biochemical characteristics of patients in GRACE risk score groups
(Abbreviations: BMI, body mass index; HT, hypertension; DM, diabetes mellitus; HPL, hyper-
lipidemia; WBC, white blood cell; NLR, neutrophil/lymphocyte ratio y p<0.001 compared with
GRACE 108-140 points, z p<0.001 compared with GRACE>140 points, * p<0.001 compared
with GRACE<108 points, ** p¼0.007 compared with GRACE<108 points, yy p¼0.01
compared with GRACE<108 points)
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Variables Odds ratio CI 95% P
NLR 3.63 1.31-10.04 0.013
_In hospital GRACE
death point
1.03 0.98-1.07 0.2
Glucose 1 0.98-1.01 0.98
Troponin T 0.978 0.461-2.078 0.95
Multivariate logistic regression analyses in hospital cardiac events
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Background and Purpose: In the setting of unstable angina/non-ST-segment
elevation acute coronary syndromes (UA/NSTEMI- ACS), diabetes mellitus particu-
larly were found to be an independent predictor of mortality. We present the treatment
trends of NSTEMI- ACS in diabetic patients in King Abdulaziz Medical city National
Guard Hospital (KAMC) in Jeddah in comparison to the whole Kingdom of
Saudi Arabia (KSA). Data are derived from the results of Multicenter International
Diabetes – Acute Coronary Syndromes (MIDAS) study.
Design: Diabetic patients presenting with UA/NSTEMI- ACS where enrolled into the
study at the time of admission to the emergency/coronary care department.
A total of 3624 patients were enrolled in several countries; 35 from KAMCamong
total of 142 from KSA.
Results: The patients enrolled were 94% type 2 DM in KSA, while in Jeddah,the
percentage was 100% and theyhad more prevalent high risk factors.
Glycoprotein IIb/IIIa inhibitorsweremore utilized appropriately in Jeddah, particularly
in the elderly, in comparison to thewholeKSA,but less than the recommendedguidelines.
While the use of Clopedogril / Ticlopidine was similarly high in both populations.
Conclusions: The non-invasive approach did not affect the trends of treatment in
KAMC. GP IIb/IIIa inhibitors are underutilized in KAMC; however it was more
utilized than the whole KSA. Clopedogril / Ticlopidineuse were optimal in both
location.LS C23
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